Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Moxifloxacin

Hy's law phenomenon: case report

    • 1 Accesses

    This is a preview of subscription content, log in to check access.

    Reference

    1. Lewis JH, et al. Hepatobiliary safety in adults with community-acquired bacterial pneumonia (CABP) treated with lefamulin (LEF) or moxifloxacin (MOX): Pooled analysis of lefamulin evaluation against pneumonia (LEAP) 1 and leap 2 study results. Open Forum Infectious Diseases 6 (Suppl. 2): S316 abstr. 699, Oct 2019. Available from: URL: http://doi.org/10.1093/ofid/ofz360.767 [abstract]

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark

    Cite this article

    Moxifloxacin. Reactions Weekly 1791, 183 (2020). https://doi.org/10.1007/s40278-020-75028-8

    Download citation